Semaglutide
Once-Weekly InjectionSemaglutide is a specialized GLP-1 (Glucagon-Like Peptide-1) receptor agonist. It acts directly on the brain’s appetite centers to increase satiety and slow digestion, keeping you feeling full for longer periods.
Data published in the New England Journal of Medicine (STEP-1 Trial) demonstrated that adults using semaglutide achieved an average reduction of 14.9% of their initial body weight over 68 weeks, compared to just 2.4% in the placebo group.